OXA-induced cell proliferation was significantly reduced by pretreatment with different pathway antagonists such as PF-04691502, wortmannin, and SB334867, indicating that the growth and proliferation in INS-1 rat insulinoma cells likely act via the AKT signaling pathway. Here, AKT1 is linked to pancreatic insulinoma.